Literature DB >> 10357471

A sensitive and versatile bioluminescence bioassay for HIV type 1 based on adenoviral vectors.

J H Axelrod1, A Honigman.   

Abstract

The construction and characterization of a versatile bioassay for the quantification of HIV-1 viral infection and HIV-1 Tat protein activity based on recombinant adenoviral vectors carrying an HIV LTR-driven luciferase reporter gene is described. The assay system consists of a set of two adeno-reporter vectors, one of which is responsive to HIV-1 Tat protein activity, and the second of which is not, by virtue of a deletion of the TAR site within the HIV LTR. This configuration of the reporter genes allows one to distinguish Tat-specific activation from Tat-non-specific HIV LTR-mediated gene expression. The adenoviral HIV LTR-mediated luciferase gene expression is highly responsive to Tat and increases linearly with increasing levels of HIV-1 infection, reaching levels of between 3- and 1000-fold induction. The adeno-reporter viruses can be utilized to detect Tat activity and HIV-1 infection in a wide range of cell types, including 293, CEM, HUT-78, Jurkat, and HeLa-derived cell lines. The resulting bioassay is convenient, sensitive, and readily adaptable to automated procedures. These characteristics of the adeno-reporter assay make it a valuable reagent for studies of HIV infection and for analysis of HIV-inhibitory agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357471     DOI: 10.1089/088922299310845

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  5 in total

1.  Adenovirus expressing a bioluminescence reporter gene and cMAGI cell assay for the detection of HIV-1.

Authors:  Gadi Borkow; Humberto Herman Lara; Mila Ayash-Rashkovsky; Einat Tavor; Aviva Lapidot; Zvi Bentwich; Alik Honigman
Journal:  Virus Genes       Date:  2004-10       Impact factor: 2.332

2.  Synchronized infection of cell cultures by magnetically controlled virus.

Authors:  Hillel Haim; Israel Steiner; Amos Panet
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages.

Authors:  Secondo Sonza; Helen P Mutimer; Kate O'Brien; Philip Ellery; Jane L Howard; Jonathan H Axelrod; Nicholas J Deacon; Suzanne M Crowe; Damian F J Purcell
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 infection inhibits granulocyte-macrophage colony-stimulating factor-induced activation of STAT5A in human monocyte-derived macrophages.

Authors:  Tammra J Warby; Suzanne M Crowe; Anthony Jaworowski
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

5.  Simian virus 40 vectors for pulmonary gene therapy.

Authors:  Luminita Eid; Zohar Bromberg; Mahmoud Abd El-Latif; Evelyn Zeira; Ariella Oppenheim; Yoram G Weiss
Journal:  Respir Res       Date:  2007-10-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.